The Glaucoma market report covers emerging drugs, current treatment practices, market share of the individual therapies, current and forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.
Glaucoma: An Overview
Glaucoma is a disease that damages the eye’s optic nerve. It usually happens when fluid builds up in the front part of the eye. That extra fluid increases the pressure in the eye, damaging the optic nerve. The condition is a leading cause of blindness for people over 60 years old. But blindness from glaucoma can often be prevented with early treatment.
There are two major types of glaucoma, i.e., Primary open-angle glaucoma (POAG), and Angle-closure /glaucoma closed-angle glaucoma/narrow-angle glaucoma. The “angle” in both cases refers to the drainage angle inside the eye that controls the outflow of the watery fluid (aqueous) which is being produced inside the eye.
Glaucoma Market Key Facts
-
The total diagnosed prevalent population of Glaucoma in the 7MM was estimated as 10,104,100+ cases in 2020.
-
The total diagnosed prevalent population of Open-angle Glaucoma (OAG) and Closed Angle Glaucoma in the US was assessed to be 2,889,300+ and 321,000+ in 2020.
-
Japan had 2,886,900+ diagnosed prevalent cases for Glaucoma in 2020.
-
Among the European five countries, Germany had the highest diagnosed prevalent population of Glaucoma with 1,042,400+ cases, followed by Italy and France in 2020. On the other hand, Spain had the lowest diagnosed cases.
-
Among the major types of Glaucoma, i.e., open-angle and close-angle glaucoma, the former one accounts for a higher number of diagnosed Glaucoma cases.
As per DelveInsight, Glaucoma Market was estimated to be USD 3,796 Million in 2020, which is expected to during the forecast period. The glaucoma market is anticipated to increase owing to the launch of upcoming therapies.
The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Glaucoma market size by analyzing the impact of current and emerging therapies in the market. It also provides a detailed assessment of the market drivers & barriers, unmet needs, and emerging technologies.
The report gives a thorough detail of the Glaucoma market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action (MoA), competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.
Glaucoma Epidemiology
The epidemiology section covers insights about the historical and current Glaucoma patient pool and forecasted trends for every seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Glaucoma Epidemiology Segmentation
-
Type-specific Diagnosed Prevalent Population of Glaucoma
-
Total Diagnosed Prevalence of Glaucoma
-
Gender-specific Diagnosed Prevalence of Glaucoma
-
Age-specific Diagnosed Prevalence of Glaucoma
-
Type-specific Diagnosed Prevalence of Open-Angle Glaucoma
Glaucoma Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Glaucoma market or expected to get launched in the market during the study period. The analysis covers the Glaucoma market uptake by drugs; patient uptake by therapies; and sales of each drug.
Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
The report also covers the Glaucoma Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisitions, and mergers, licensing patent details, and other information for emerging therapies.
Get the PDF Sample of the Report:- https://www.delveinsight.com/sample-request/glaucoma-market
Glaucoma Therapeutics Analysis
The dynamics of the Glaucoma market is anticipated to change in the coming years owing to the improvement in the diagnosis methodologies, rising awareness of the diseases, incremental healthcare spending across the world, and also expects the launch of emerging therapies and devices. Treatment options for Glaucoma are rapidly expanding. However, still, there is no cure available.
Key Companies in the Glaucoma Market include:
-
Kowa Company/D.Western Therapeutics Institute
-
Peregrine Ophthalmic
-
Ocuphire Pharma
-
Envisia Therapeutics
-
Sylentis
-
Nicox Ophthalmics
-
Santen Inc./Ono Pharmaceutical
-
Santen Pharmaceutical
-
Perrigo Company
-
Laboratorios Sophia S.A de C.V.
-
Sun Pharma Advanced Research Company Limited (SPARC)
And many others
Some of the Glaucoma Therapies covered in the report include:
-
PDP-716
-
PRO-122
-
Brinzolamide Ophthalmic Suspension 1%
-
DE-130A (Catioprost)
-
Sepetaprost (DE-126/ONO-9054)
-
NCX 470
-
Bamosiran (SYL040012)
-
ENV515 (Travoprost XR)
-
Nyxol (Phentolamine Mesylate)
-
POLAT-001
-
Ripasudil hydrochloride hydrate/Brimonidine tartrate (K-232)
And many more
Get More Detailed Insights into the Emerging Therapies & Key Companies:- https://www.delveinsight.com/sample-request/glaucoma-market
Table of Content
1. Key Insights
2. Executive Summary
3. Glaucoma Competitive Intelligence Analysis
4. Glaucoma Market Overview at a Glance
5. Glaucoma Disease Background and Overview
6. Glaucoma Patient Journey
7. Glaucoma Epidemiology and Patient Population
8. Glaucoma Treatment Algorithm, Current Treatment, and Medical Practices
9. Glaucoma Unmet Needs
10. Key Endpoints of Glaucoma Treatment
11. Glaucoma Marketed Products
12. Glaucoma Emerging Therapies
13. Glaucoma Seven Major Market Analysis
14. Attribute Analysis
15. Glaucoma Market Outlook (7 major markets)
16. Glaucoma Access and Reimbursement Overview
17. KOL Views on the Glaucoma Market.
18. Glaucoma Market Drivers
19. Glaucoma Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
*The table of contents is not exhaustive; the final content may vary.
Request Sample Report here:- https://www.delveinsight.com/sample-request/glaucoma-market
Other Trending Healthcare Reports By DelveInsight
Bacterial (Pyogenic) Meningitis Market
DelveInsight’s “Bacterial (Pyogenic) Meningitis Market” research report delivers an in-depth understanding of the historical and forecasted epidemiology, Bacterial (Pyogenic) Meningitis market size, share, trends, emerging therapies, and key companies operating in the market.
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/